CHARENTON-LE-PONT, France, September 10 /PRNewswire-FirstCall/ -- Essilor is pursuing its growth strategy in Eastern Europe's markets by acquiring a majority stake in Omega Optix. The company is a leading operator in the Czech Republic and Slovakia, where its prescription laboratories generate total revenue of more than EUR10 million.
In addition to ensuring the long-term viability of a recognized market player, the acquisition will enable Essilor to offer local customers an alternative lineup of products and services, thereby driving fast growth in a rapidly developing market.
The current Omega Optix management team will remain in place and
continue to operate the company independently.
Essilor International is the world leader in ophthalmic optical
products, offering a wide range of lenses under the flagship Varilux(R),
Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia,
presbyopia and astigmatism. Essilor operates worldwide through 15
production sites, 270 lens finishing laboratories and local distribution
networks. The Essilor share trades on the Euronext Paris market and is
included in the CAC 40 index. Codes and symbols: ISIN: FR 0000121667;
Reuters: ESSI.PA; Bloomberg: EF:FP
Investor Relations and Financial Communications
Veronique Gillet - Sebastien Leroy
Copyright©2008 PR Newswire.
All rights reserved